Uncovering a Tumor Suppressor for Triple-Negative Breast Cancers

“Triple-negative” breast cancers are aggressive malignancies that respond poorly to treatments. Now find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.